UNSPSC 85892557: Low dose rate (ldr) brachytherapy of left breast using iridium 192 (ir-192)

This classification denotes the group of activities that yields a radiation therapy intervention or procedure of low dose rate (ldr) brachytherapy of left breast using iridium 192 (ir-192). This intervention or procedure is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as code DM10B8Z

UNSPSC 85892557 Low dose rate brachytherapy of left breast using iridium 192 (Ir-192) is a Commodity code that shows little relevant recent activity in state and local procurement. The single recent opportunity tagged to this code — County of Santa Clara Health System Solicitation RFSQHHSFY270052, posted July 7, 2026, with proposals due October 7, 2026 — solicits temporary health professional staffing services across ancillary clinical categories including audiology, cardiology, diagnostic imaging, gastroenterology, ophthalmology, orthopedic, respiratory care, sterile processing, surgical and operating room support, and therapy services. This staffing solicitation bears no relationship to the code's nominal scope of specialized radiation oncology brachytherapy procedures and represents a classification mismatch rather than authentic activity under the code.

The County of Santa Clara Health System's staffing RFQ establishes a non-exclusive, multiple-award qualified vendor pool with no guaranteed work volume, with the Health System reserving the right to maintain the Qualified List for five years and contract with selected vendors as operational needs arise. Proposers may self-select and submit qualifications for all or specific health professional categories; placement on the Qualified List does not guarantee contract award. The absence of additional recent opportunities and the clear mismatch between the brachytherapy code name and the staffing services being solicited indicate that this Commodity code does not reflect active state and local procurement demand for the specialized oncology procedure it nominally describes.